Krazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12

Plus news about Structure Therapeutics, Cloverleaf Bio and Windward Bio. FDA finalizes Krazati withdrawal: Regulators officially finalized the drug’s withdrawal in second-line colorectal cancer last week. Krazati had